Business Summary
- sale of under licenses officinal medicines (50.9%);
- sale of generic officinal medicines (43.8%);
- sale of medicines to hospitals (2.2%);
- shaping services (0.8%): manufactured products packaging services ;
- other (0.1%).
The remaining sales (3%) are from international activities.
Number of employees: 543
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tarek Hammami
CEO | Chief Executive Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mounir Jerbi
BRD | Director/Board Member | - | - |
Tarek Hammami
CEO | Chief Executive Officer | - | - |
Director/Board Member | - | 31/12/20 | |
Director/Board Member | - | - | |
Sara Masmoud
CHM | Chairman | - | 31/12/21 |
Hajer Elloumi
BRD | Director/Board Member | - | - |
Sami Ben Ayed
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,528,000 | 5,269,558 ( 24.48 %) | 0 | 24.48 % |
Company contact information
![address Société ADWYA S.A(ADWYA)](https://cdn.zonebourse.com/static/address/13962891.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |